NCT02428712: An ongoing trial by Fore Biotherapeutics
This trial is completed, but has been granted a delay in reporting its results.
It must report results 1 year, 6 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT02428712 |
|---|---|
| Title | A Phase 1/2a Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of FORE8394 in Patients With Advanced Unresectable Solid Tumors |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | April 30, 2015 |
| Completion date | July 12, 2024 |
| Required reporting date | July 12, 2027, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |